Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3237-3248

  St Louis, Daniel C ^a,b   Woodcock, Juliana B ^a   Fransozo, Guido ^c   Blair, Patrick J ^a   Carlson, Louise M ^c   Murillo, Maria ^a   Wells, Mark R ^a   Williams, Amanda J ^a   Smoot, Douglas S ^a   Kaushal, Sumesh ^a,b   Grimes, Janelle L ^a   Harlan, David M ^a,d   Chute, John P ^a,d   June, Carl H ^a,d   Siebenlist, Ulrich ^c   Lee, Kelvin P ^a,d  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; DENDRITIC CELL; ENZYME ACTIVATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD34; ANTIGENS, SURFACE; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CYTOKINES; DENDRITIC CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; MACROMOLECULAR SUBSTANCES; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0033559536     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. + dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 88:4029.
3. + peripheral blood monocytes. J. Immunol. 157:3850.
4. + dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588.
5. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J. Leukocyte Biol. 59:208.
6. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3:459.
7. Ryncarz, R. E., and C. Anasetti. 1998. Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells. Blood 91:3892.
8. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures J. Exp. Med. 185:317.
9. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
10. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 2:341.
11. Czerniecki, B. J., C. Carter, L. Rivoltini, G. K. Koski, H. I. Kim, D. E. Weng, J. G. Roros, Y. M. Hijazi, S. Wu, S. A. Rosenberg, et al. 1997. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J. Immunol. 159:3823.
12. Hart, D. N. 1998. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245.
13. Reddy, A., M. Sapp, M. Feldman, M. Subklewe, and N. Bhardwaj. 1997. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 90:3640.
14. + hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J. Immunol. 160:3689.
15. Arruda, S., and J. L. Ho. 1992. IL-4 receptor signal transduction in human monocytes is associated with protein kinase C translocation. J. Immunol. 149:1258.
16. Harnett, M. M., M. J. Holman, and G. G. Klaus. 1991. IL-4 promotes anti-lg-mediated protein kinase C translocation and reverses phorbol ester-mediated protein kinase C down-regulation in murine B cells. J. Immunol. 147:3831.
17. Finney, M., G. R. Guy, R. H. Michell, J. Gordon, B. Dugas, K. P. Rigley, and R. E. Callard. 1990. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur. J. Immunol. 20:151.
18. Schutze, S., T. Machleidt, and M. Kronke. 1994. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J. Leukocyte Biol. 56:533.
19. Ren, C. L., S. M. Fu, R. S. Geha, and T. Morio. 1994. Protein tyrosine kinase activation and protein kinase C translocation are functional components of CD40 signal transduction in resting human B cells: signal transduction via CD40 involves activation of Lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med. 179:673.
20. Sallusto, F., C. Nicolo, R. De Maria, S. Corinti, and R. Testi. 1996. Ceramide inhibits antigen uptake and presentation by dendritic cells. J. Exp. Med. 184: 2411.
21. Carrasco, D., R. P. Ryseck, and R. Bravo. 1993. Expression of RelB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118:1221.
22. Boehmelt, G., J. Madruga, P. Dorfler, K. Briegel, H. Schwarz, P. J. Enrietto, and M. Zenke. 1995. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell 80:341.
23. Feuillard, J., M. Komer, A. Israel, J. Vassy, and M. Raphael. 1996. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ. Eur. J. Immunol. 26:2547.
24. Lernbecher, T., B. Kistler, and T. Wirth. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13:4060.
25. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
26. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB. a member of the NF-κB/Rel family. Cell 80:331.
27. Sekhar, M., H. Kotani, S. Doren, R. Agarwal, G. McGarrity, and C. E. Dunbar. 1996. Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions. Hum. Gene Ther. 7:33.
28. Koeffler, H. P., and D. W. Golde. 1978. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200:1153.
29. Koeffler, H. P., M. Bar-Eli, and M. C. Territo. 1981. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res. 41:919.
30. Kiss, Z., E. Deli, M. Shoji, H. P. Koeffler, G. R. Pettit, W. R. Vogler, and J. F. Kuo. 1987. Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a. Cancer Res. 47:1302.
31. Ferrero, D., S. Pessano, G. L. Pagliardi, and G. Rovera. 1983. Induction of differentiation of human myeloid leukemias: surface changes probed with monoclonal antibodies. Blood 61:171.
32. Koeffler, H. P., R. Billing, A. J. Lusis, R. Sparkes, and D. W. Golde. 1980. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56:265.
33. Shoji, M., P. R. Girard, P. A. Charp, H. P. Koeffler, W. R. Vogler, and J. F. Kuo. 1987. Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a. Cancer Res. 47:6163.
34. 3H]phorbol dibutyrate to phorbol diester-responsive and resistant clones of a human myeloid leukemia (KG-1) line 1. Cancer Res. 43:3563.
35. Davis, T. A., D. H. Robinson, K. P. Lee, and S. W. Kessler. 1995. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors. Blood 85: 1751.
36. Koopman, G., C. P. Reutelingsperger, G. A. Kuijten, R. M. Keehnen, S. T. Pals, and M. H. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415.
37. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompalibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389.
38. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resiscant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
39. Lee, K. P., C. Taylor, B. Petryniak, L. A. Turka, C. H. June, and C. B. Thompson. 1990. The genomic organization of the CD28 gene: implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol. 145:344.
40. Meggio, F., A. Donella Deana, M. Ruzzene, A. M. Brunati, L. Cesaro, B. Guerra, T. Meyer, H. Mett, D. Fabbro, and P. Furet. 1995. Different susceptibility of protein kinases to staurosporine inhibition: kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur. J. Biochem. 234:317.
41. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154-3821.
42. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
43. Fearnley, D. B., A. D. McLellan, S. I. Mannering, B. D. Hock, and D. N. Hart. 1997. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy. Blood 89:3708.
44. Territo, M. C., and H. P. Koeffler. 1981. Induction by phorhol esters of macrophage differentiation in human leukaemia cell lines does not require cell division Br. J. Haematol. 47:479.
45. Thomas, R., L. S. Davis, and P. E. Lipsky. 1993. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J. Immunol. 151:6840.
46. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon. J. Foster, Y. Xu, P. Nooyen, T. McClanahan, et al. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713.
47. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484.
48. Kazanietz, M. G., N. E. Lewin, J. D. Bruns, and P. M. Blumberg. 1995. Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor: analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity. J. Biol. Chem. 270:10777.
49. rac-GTPase activating protein n-chimaerin. J. Biol. Chem. 268:10709.
50. Ahmed, S., I. N. Maruyama, R. Kozma, J. Lee, S. Brenner, and L. Lim. 1992. The Caenorhabditis elegans unc-13 gene product is a phospholipid-dependent high-affinity phorbol ester receptor. Biochem. J. 287:995.
51. Monks, C. R. F., H. Kupper, I. Tamir, A. Barlow, and A. Kupfer. 1997. Selective modulation of protein kinase c-θ during T-cell activation. Nature 385:83.
52. Macfarlane, D. E., and L. Manzel. 1994. Activation of B-isozyme of protein kinase C (PKCβ) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytcs: studies with PKCβ-detective PET mutant J. Biol. Chem. 269:4327.
53. Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1993. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA 90:3038.
54. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
55. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
56. Santiago-Schwarz, F., E. Belilos, B. Diamond, and S. E. Carsons. 1992. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J. Leukocyte Biol. 52:274.
57. + progenitors in human bone marrow. J. Immunol. 149:2681.
58. + hematopoietic precursor cells. Blood 87: 535.
59. + hematopoietic progenitor cells. Blood 75:2292.
60. Scheicher, C., M. Mehlig, R. Zecher, and K. Reske. 1992. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 154: 253.
61. Markowicz, S., and E. G. Engleman. 1990. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J. Clin. Invest. 85:955.
62. Witmer-Pack, M. D., W. Olivier, J. Valinsky, G. Schuler, and R. M. Steinman. 1987. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166:1484.
63. + bone marrow precursors cultured with c-Kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J. Immunol. 154:5851.
64. + bone marrow progenitors thai are expanded by c-Kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J. Exp. Med. 182:1111.
65. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
66. + derived dendritic/Langerhans cells (D-Lc). Adv. Exp. Med. Biol. 378:1.
67. Szabolcs, P., D. Avigan, S. Gezelter, D. H. Ciocon, M. A. Moore, R. M. Steinman, and J. W. Young. 1996. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 87:4520.
68. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 2:341.
69. Mufson, R. A. 1997. The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction. FASEB J. 11:37.
70. Choudhury, A., J. L. Gajewski, J. C. Liang, U. Popat, D. F. Claxton, K. O. Kliche, M. Andreeff, and R. E. Champlin. 1997. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89:1131.
71. Koeffler, H. P., R. Billing, A. J. Lusis, R. Sparkes, and D. W. Golde. 1980. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56:265.
72. Furley, A. J., B. R. Reeves, S. Mizutani, L. J. Altass, S. M. Watt, M. C. Jacob, P. van den Elsen, C. Terhorst, and M. F. Greaves. 1986. Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines. Blood 68:1101.
73. Fukuda, M., H. P. Koeffler, and J. Minowada. 1981. Membrane differentiation in human myeloid cells: expression of unique profiles of cell surface glycoproteins in myeloid leukemic cell lines blocked at different stages of differentiation and maturation. Proc. Natl. Acad. Sci. USA 78:6299.
74. Koeffler, H. P., M. Bar-Eli, and M. C. Territo. 1981. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res. 41:919.
75. Shoji, M., P. R. Girard, P. A. Charp, H. P. Koeffler, W. R. Vogler, and J. F. Kuo. 1987. Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a. Cancer Res. 47:6363.
76. Bettaieb, A., M. Record, M. G. Come, A. C. Bras, H. Chap, G. Laurent, and J. P. Jaffrezou. 1996. Opposite effects of tumor necrosis factor α on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: role of transverse sphingomyelin distribution in the plasma membrane. Blood 88:1465.
77. Bezombes, C., N. Maestre, G. Laurent, T. Levade, A. Bettaieb, and J. P. Jaffrezou. 1998. Restoration of TNF-α-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J. 12:101.
78. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
79. Boehmelt, G., J. Madruga, P. Dorfler, K. Briegel, H. Schwarz, P. J. Enrietto, and M. Zenke. 1995. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell 80:341.
80. Ryseck, R. P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674.
81. Tewari, M., P. Dobrzanski, K. L. Mohn, D. E. Cressman, J. C. Hsu, R. Bravo, and R. Taub. 1992. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site-binding complex. Mol. Cell. Biol. 12:2898.
82. Carrasco, D., R. P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118:1221.
83. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
84. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB. a member of the NF-κB/Rel family. Cell 80:331.
85. Pettit, A. R., C. Quinn, K. P. A. MacDonald, L. L. Cavanagh, G. Thomas, W. Townsend, M. Handel, and R. Thomas. 1997. Nuclear localization of RelB is associated with effective antigen-presenting cell function. J. Immunol. 159:3681.
86. Olashaw, N. E. 1996. Inducible activation of RelB in fibroblasts. J. Biol. Chem. 271:30307.